IDEAYA Biosciences Ownership 2024 | Who Owns IDEAYA Biosciences Now?
Institutional Ownership
18.22%
Insider Ownership
1.06%
Retail Ownership
80.72%
Institutional Holders
67.00
IDEAYA Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 14.46% | 0.03% | 11,270,083 | 1,114,829 | 10.98% | 395,692,626 | Jun 30, 2024 |
| BLACKROCK INC. | 8.73% | 0.01% | 6,807,790 | 842,377 | 14.12% | 239,021,508 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 6.23% | 0.40% | 4,855,790 | -288 | -0.01% | 170,486,787,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.47% | 0.00% | 4,266,773 | 111,016 | 2.67% | 149,806,400 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 5.23% | 0.08% | 4,076,020 | 267,570 | 7.03% | 143,104,277 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.80% | 0.02% | 3,743,741 | -308,759 | -7.62% | 131,444,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.69% | 0.00% | 2,874,296 | -289,658 | -9.15% | 100,916,533,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.83% | 4.07% | 2,202,812 | - | - | 77,340,729 | Jun 30, 2024 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 2.78% | 0.02% | 2,164,551 | 187,681 | 9.49% | 75,997,386 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.69% | 1.23% | 2,097,113 | -533,179 | -20.27% | 73,629,637 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.65% | 0.13% | 2,065,094 | -402,013 | -16.29% | 72,505,450 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.40% | 0.27% | 1,871,873 | 256,225 | 15.86% | 65,721,461 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.27% | 0.01% | 1,772,617 | 206,902 | 13.21% | 62,249,272 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.18% | 4.85% | 1,700,000 | 200,000 | 13.33% | 59,687,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.04% | 0.06% | 1,587,499 | 314,653 | 24.72% | 55,737,090 | Jun 30, 2024 |
| FIERA CAPITAL CORP | 1.71% | 0.15% | 1,335,410 | 246,010 | 22.58% | 46,886,245 | Jun 30, 2024 |
| BVF INC/IL | 1.49% | 1.14% | 1,162,306 | - | - | 40,808,564 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.48% | 2.10% | 1,151,528 | 369,932 | 47.33% | 40,430,148 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.43% | 1.67% | 1,117,000 | 317,300 | 39.68% | 39,217,870 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.40% | 0.01% | 1,094,872 | -269,467 | -19.75% | 38,437,251 | Jun 30, 2024 |
IDEAYA Biosciences's largest institutional shareholder is FMR LLC, holding 14.46% of the company's total share outstanding, currently valued at $395.69M. The top 10 institutional shareholders own together 56.90% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LOGOS GLOBAL MANAGEMENT LP | 2.18% | 4.85% | 1,700,000 | 200,000 | 13.33% | 59,687,000 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 2.83% | 4.07% | 2,202,812 | - | - | 77,340,729 | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 0.54% | 3.86% | 422,049 | -109,918 | -20.66% | 14,818,140 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.54% | 3.54% | 422,213 | -24,128 | -5.41% | 14,823,898 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.51% | 2.27% | 397,782 | - | - | 13,966,126 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.89% | 2.15% | 694,069 | 160,554 | 30.09% | 24,368,763 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.48% | 2.10% | 1,151,528 | 369,932 | 47.33% | 40,430,148 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.43% | 1.67% | 1,117,000 | 317,300 | 39.68% | 39,217,870 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.97% | 1.61% | 759,516 | -163,162 | -17.68% | 26,666,607 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.69% | 1.23% | 2,097,113 | -533,179 | -20.27% | 73,629,637 | Jun 30, 2024 |
| BVF INC/IL | 1.49% | 1.14% | 1,162,306 | - | - | 40,808,564 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | 0.13% | 1.05% | 101,787 | 14,394 | 16.47% | 3,573,742 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.05% | 0.52% | 40,856 | -58,436 | -58.85% | 1,434,454 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.31% | 0.50% | 245,000 | -205,000 | -45.56% | 8,601,950 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 1.36% | 0.48% | 1,062,123 | - | - | 37,291,139 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 6.23% | 0.40% | 4,855,790 | -288 | -0.01% | 170,486,787,000 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.07% | 0.37% | 54,392 | 1,900 | 3.62% | 1,909,703 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 0.78% | 0.36% | 611,820 | 130,595 | 27.14% | 21,480,999 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.40% | 0.27% | 1,871,873 | 256,225 | 15.86% | 65,721,461 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.09% | 0.26% | 71,036 | -84,784 | -54.41% | 2,494,074 | Jun 30, 2024 |
The largest IDEAYA Biosciences shareholder by % of total assets is LOGOS GLOBAL MANAGEMENT LP. The company owns 1.70M shares of IDEAYA Biosciences (IDYA), representing 4.85% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 14.46% | 0.03% | 11,270,083 | 1,114,829 | 10.98% | 395,692,626 | Jun 30, 2024 |
| BLACKROCK INC. | 8.73% | 0.01% | 6,807,790 | 842,377 | 14.12% | 239,021,508 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.48% | 2.10% | 1,151,528 | 369,932 | 47.33% | 40,430,148 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.50% | 0.02% | 388,252 | 327,737 | 541.58% | 13,631,528 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 1.43% | 1.67% | 1,117,000 | 317,300 | 39.68% | 39,217,870 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.04% | 0.06% | 1,587,499 | 314,653 | 24.72% | 55,737,090 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.35% | 0.07% | 276,798 | 276,798 | 100.00% | 9,718,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 5.23% | 0.08% | 4,076,020 | 267,570 | 7.03% | 143,104,277 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.33% | 0.01% | 258,170 | 258,170 | 100.00% | 9,064,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.87% | 0.00% | 676,734 | 257,835 | 61.55% | 23,760,131 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 2.40% | 0.27% | 1,871,873 | 256,225 | 15.86% | 65,721,461 | Jun 30, 2024 |
| FIERA CAPITAL CORP | 1.71% | 0.15% | 1,335,410 | 246,010 | 22.58% | 46,886,245 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.13% | 0.03% | 884,538 | 226,514 | 34.42% | 31,056,129 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.27% | 0.01% | 1,772,617 | 206,902 | 13.21% | 62,249,272 | Jun 30, 2024 |
| LOGOS GLOBAL MANAGEMENT LP | 2.18% | 4.85% | 1,700,000 | 200,000 | 13.33% | 59,687,000 | Jun 30, 2024 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 2.78% | 0.02% | 2,164,551 | 187,681 | 9.49% | 75,997,386 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.21% | 0.02% | 165,776 | 165,776 | 100.00% | 5,820,395 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 0.89% | 2.15% | 694,069 | 160,554 | 30.09% | 24,368,763 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 0.53% | 0.01% | 410,862 | 154,613 | 60.34% | 14,425,363 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 0.78% | 0.36% | 611,820 | 130,595 | 27.14% | 21,480,999 | Jun 30, 2024 |
As of Jun 30 2024, IDEAYA Biosciences's largest institutional buyer is FMR LLC. The company purchased 1.11M stocks of IDYA, valued at $395.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.69% | 1.23% | 2,097,113 | -533,179 | -20.27% | 73,629,637 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.65% | 0.13% | 2,065,094 | -402,013 | -16.29% | 72,505,450 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -335,471 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.80% | 0.02% | 3,743,741 | -308,759 | -7.62% | 131,444,000 | Jun 30, 2024 |
| STATE STREET CORP | 3.69% | 0.00% | 2,874,296 | -289,658 | -9.15% | 100,916,533,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.40% | 0.01% | 1,094,872 | -269,467 | -19.75% | 38,437,251 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -217,070 | -100.00% | - | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.31% | 0.50% | 245,000 | -205,000 | -45.56% | 8,601,950 | Jun 30, 2024 |
| INVESCO LTD. | 0.17% | 0.00% | 129,924 | -168,769 | -56.50% | 4,561,632 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 0.97% | 1.61% | 759,516 | -163,162 | -17.68% | 26,666,607 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.08% | 0.00% | 64,912 | -148,602 | -69.60% | 2,279,061 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -123,900 | -100.00% | - | Jun 30, 2024 |
| BOONE CAPITAL MANAGEMENT LLC | 0.54% | 3.86% | 422,049 | -109,918 | -20.66% | 14,818,140 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.33% | 0.00% | 255,293 | -105,789 | -29.30% | 8,963,337 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.02% | 0.00% | 13,371 | -100,666 | -88.27% | 469,456 | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.09% | 0.26% | 71,036 | -84,784 | -54.41% | 2,494,074 | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -83,484 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.17% | 0.02% | 131,096 | -70,195 | -34.87% | 4,602,781 | Jun 30, 2024 |
| HARVEST INVESTMENT SERVICES, LLC | - | - | - | -66,744 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -66,332 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, IDEAYA Biosciences's biggest institutional seller is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The company sold -0.53M shares of IDYA, valued at $73.63M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.35% | 0.07% | 276,798 | 276,798 | 100.00% | 9,718,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.33% | 0.01% | 258,170 | 258,170 | 100.00% | 9,064,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.21% | 0.02% | 165,776 | 165,776 | 100.00% | 5,820,395 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.14% | 0.01% | 109,325 | 109,325 | 100.00% | 3,838,401 | Jun 30, 2024 |
| NORGES BANK | 0.12% | 0.00% | 92,600 | 92,600 | 100.00% | 3,251,186 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.07% | 0.18% | 53,500 | 53,500 | 100.00% | 1,878,385 | Jun 30, 2024 |
| MAGNETAR FINANCIAL LLC | 0.06% | 0.03% | 45,550 | 45,550 | 100.00% | 1,599,261 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 40,214 | 40,214 | 100.00% | 1,411,914 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 38,691 | 38,691 | 100.00% | 1,355,093 | Jun 30, 2024 |
| HANDELSBANKEN FONDER AB | 0.03% | 0.00% | 23,400 | 23,400 | 100.00% | 822,000 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.02% | 0.08% | 12,420 | 12,420 | 100.00% | 436,066 | Jun 30, 2024 |
| SNOWDEN CAPITAL ADVISORS LLC | 0.01% | 0.01% | 11,274 | 11,274 | 100.00% | 395,830 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.01% | 0.01% | 10,154 | 10,154 | 100.00% | 356,507 | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.01% | 0.23% | 4,392 | 4,392 | 100.00% | 154,203 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 1,900 | 1,900 | 100.00% | 66,709 | Jun 30, 2024 |
| CI INVESTMENTS INC. | 0.00% | 0.00% | 1,786 | 1,786 | 100.00% | 63,000 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.00% | 0.01% | 1,178 | 1,178 | 100.00% | 41,360 | Jun 30, 2024 |
| ITAU UNIBANCO HOLDING S.A. | 0.00% | 0.00% | 557 | 557 | 100.00% | 19,556 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.00% | 0.00% | 417 | 417 | 100.00% | 14,641 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 300 | 300 | 100.00% | 10,533 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 255 | 255 | 100.00% | 8,953 | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | 0.00% | 0.00% | 98 | 98 | 100.00% | 3,441 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 68 | 68 | 100.00% | 2,337 | Jun 30, 2024 |
| NEWEDGE ADVISORS, LLC | 0.00% | - | 50 | 50 | 100.00% | 1,756 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | 18 | 18 | 100.00% | 632 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 18 | 18 | 100.00% | 632 | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | 14 | 14 | 100.00% | 603 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | 8 | 8 | 100.00% | 281,000 | Jun 30, 2024 |
IDEAYA Biosciences's largest new institutional shareholder by number of shares is EXODUSPOINT CAPITAL MANAGEMENT, LP, purchased 276.80K shares, valued at $9.72M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FIRST LIGHT ASSET MANAGEMENT, LLC | - | - | - | -335,471 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | - | - | - | -217,070 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -123,900 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -83,484 | -100.00% | - | Jun 30, 2024 |
| HARVEST INVESTMENT SERVICES, LLC | - | - | - | -66,744 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -66,332 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -59,180 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -42,943 | -100.00% | - | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | - | - | - | -33,007 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -32,430 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -23,354 | -100.00% | - | Jun 30, 2024 |
| SEI INVESTMENTS CO | - | - | - | -15,722 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -15,473 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -15,237 | -100.00% | - | Jun 30, 2024 |
| BOSTON PARTNERS | - | - | - | -13,391 | -100.00% | - | Jun 30, 2024 |
| REDMOND ASSET MANAGEMENT, LLC | - | - | - | -12,754 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -11,200 | -100.00% | - | Jun 30, 2024 |
| CIBC WORLD MARKET INC. | - | - | - | -8,867 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -5,850 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -5,000 | -100.00% | - | Jun 30, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -4,942 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -4,888 | -100.00% | - | Jun 30, 2024 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | - | - | - | -4,877 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,460 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -2,994 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -1,497 | -100.00% | - | Jun 30, 2024 |
| COVESTOR LTD | - | - | - | -1,119 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -442 | -100.00% | - | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| FIRST COMMAND ADVISORY SERVICES, INC. | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| GENEOS WEALTH MANAGEMENT INC. | - | - | - | -15 | -100.00% | - | Jun 30, 2024 |
IDEAYA Biosciences's largest sold out institutional shareholder by shares sold is FIRST LIGHT ASSET MANAGEMENT, LLC, sold -0.34M shares, valued at -, as of undefined.
IDEAYA Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. | 0.35% | 1,765,435 | 43,172 | 2.51% | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.28% | 133,185 | - | - | Mar 31, 2024 |
| Federated Hermes Equity Funds | 0.25% | 4,821,279 | 982,279 | 25.59% | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.15% | 4,439,500 | 4,439,500 | - | Feb 29, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.11% | 7,786 | - | - | Sep 30, 2022 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.09% | 294,951 | 56,569 | 23.73% | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.08% | 27,909 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.07% | 194,992 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 36,478 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.06% | 15,805 | - | - | Mar 31, 2024 |
| Jacob Funds Inc. | 0.05% | 11,125 | -6,542 | -37.03% | Feb 29, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.04% | 85,296 | 85,296 | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.04% | 134,265 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.04% | 53,313 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 1,778,740 | - | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 10,320 | -2,710 | -20.80% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 77,530 | -41,767 | -35.01% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 45,000 | - | - | Mar 28, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 115,330 | 6,103 | 5.59% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,208,957 | 292,000 | 31.84% | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,847 | 679 | 7.41% | Mar 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.01% | 61,093 | 16,493 | 36.98% | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.01% | 2,292 | -1,531 | -40.05% | Mar 28, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,401,315 | -430,838 | -11.24% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.01% | 19,680 | - | - | Jan 31, 2024 |
| Nushares ETF Trust | 0.01% | 51,911 | -8,772 | -14.46% | Jan 31, 2024 |
| Bernstein Fund Inc | 0.01% | 55,330 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 56,452 | -42,710 | -43.07% | Mar 28, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 1,777,767 | 1,362,017 | 327.60% | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 7,313 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 21,567 | -9,162 | -29.82% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 950 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.00% | 40,714 | 40,714 | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 168,194 | 16,719 | 11.04% | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 45,790 | 5,136 | 12.63% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 103,020 | -23,860 | -18.81% | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 6,615 | -801 | -10.80% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 607,562 | 74,686 | 14.02% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 6,562 | 332 | 5.33% | Mar 31, 2024 |
| ETFis Series Trust I | 0.00% | 2,398 | -1,579 | -39.70% | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,455 | 637 | 10.95% | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 44,367 | 4,586 | 11.53% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 185,640 | 84,235 | 83.07% | Jan 31, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 19,834 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 5,169 | -231 | -4.28% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,056,057 | 332,249 | 45.90% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 84,097 | -72,016 | -46.13% | Jan 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 4,068 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 10,730 | -616 | -5.43% | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 1,524 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 15,883 | -1,109 | -6.53% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 604 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 8,170 | 2,784 | 51.69% | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 291,887 | 47,184 | 19.28% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,629 | -3,033 | -12.82% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,130 | 134 | 4.47% | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,484 | - | - | Mar 28, 2024 |
| Global X Funds | 0.00% | 27,153 | 2,400 | 9.70% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 146,738 | 60,047 | 69.27% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 17,181 | 4,113 | 31.47% | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 339,500 | 47,555 | 16.29% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,906 | -568 | -7.60% | Mar 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 34,089 | -61,063 | -64.17% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 118,517 | 67,077 | 130.40% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 67,978 | -9,613 | -12.39% | Mar 28, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 2,958 | 2,958 | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,319 | 2,319 | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 2,172 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 36,133 | -19,154 | -34.64% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 23,350 | 1,850 | 8.60% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 107,453 | 14,986 | 16.21% | Feb 29, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 6,828 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 3,078 | 3,078 | - | Mar 28, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 3,637 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 5,899 | 2,248 | 61.57% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 825 | - | - | Mar 31, 2024 |
| MAINSTAY FUNDS TRUST | 0.00% | 62,502 | 62,502 | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 4,393 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 5,654 | 905 | 19.06% | Feb 29, 2024 |
| SunAmerica Specialty Series | 0.00% | 131 | - | - | Apr 30, 2021 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 12,528 | - | - | Mar 31, 2024 |
| Victory Portfolios II | 0.00% | 12,241 | 86 | 0.71% | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 15,000 | -600 | -3.85% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,929,562 | 156,360 | 5.64% | Mar 31, 2024 |
| Dunham Funds | 0.00% | 12,077 | -15,358 | -55.98% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 15,458 | 3,456 | 28.80% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 22,785 | 13,503 | 145.48% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 15,653 | -2,492 | -13.73% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 191,216 | 17,451 | 10.04% | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 6,126 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 272,051 | 55,311 | 25.52% | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 7,130 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 544 | 49 | 9.90% | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 105,228 | -11,578 | -9.91% | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 900 | 900 | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 10,253 | -286 | -2.71% | Feb 29, 2024 |
| FundVantage Trust | 0.00% | 1,312 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 23,097 | 2,176 | 10.40% | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 335,000 | - | - | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 33,625 | 33,625 | - | Jan 31, 2024 |
IDEAYA Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price New Horizons Fund, Inc.", owning 1.77M shares, compromising 0.35% of its total assets.
IDEAYA Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 67 | -67.48% |
| 31 Mar, 24 | 206 | 29.56% |
| 31 Dec, 23 | 159 | 8.90% |
| 30 Sep, 23 | 146 | 2.82% |
| 30 Jun, 23 | 142 | 11.81% |
| 31 Mar, 23 | 127 | 4.96% |
| 31 Dec, 22 | 121 | 6.14% |
| 30 Sep, 22 | 114 | 16.33% |
| 30 Jun, 22 | 98 | -5.77% |
| 31 Mar, 22 | 104 | -6.31% |
| 31 Dec, 21 | 111 | 23.33% |
| 30 Sep, 21 | 90 | 8.43% |
| 30 Jun, 21 | 83 | -8.79% |
| 31 Mar, 21 | 91 | 9.64% |
| 31 Dec, 20 | 83 | 25.76% |
| 30 Sep, 20 | 66 | 4.76% |
| 30 Jun, 20 | 63 | 142.31% |
| 31 Mar, 20 | 26 | -13.33% |
| 31 Dec, 19 | 30 | 25.00% |
| 30 Sep, 19 | 24 | - |
| 30 Jun, 19 | 24 | - |
As of 30 Jun 24, 67 institutions are holding IDEAYA Biosciences's shares, representing a decrease of -67.48% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 14,201,004 | -82.03% |
| 31 Mar, 24 | 79,028,458 | 19.50% |
| 31 Dec, 23 | 66,131,446 | 10.78% |
| 30 Sep, 23 | 59,696,179 | 5.49% |
| 30 Jun, 23 | 56,588,010 | 24.27% |
| 31 Mar, 23 | 45,537,780 | -1.15% |
| 31 Dec, 22 | 46,069,105 | 3.02% |
| 30 Sep, 22 | 44,716,764 | 26.20% |
| 30 Jun, 22 | 35,432,949 | 1.03% |
| 31 Mar, 22 | 35,072,346 | 0.99% |
| 31 Dec, 21 | 34,727,068 | 5.71% |
| 30 Sep, 21 | 32,852,571 | 29.33% |
| 30 Jun, 21 | 25,402,126 | 6.65% |
| 31 Mar, 21 | 23,818,104 | 17.42% |
| 31 Dec, 20 | 20,283,888 | 7.44% |
| 30 Sep, 20 | 18,878,404 | 2.26% |
| 30 Jun, 20 | 18,460,926 | 69.04% |
| 31 Mar, 20 | 10,921,124 | -2.08% |
| 31 Dec, 19 | 11,153,168 | 100.14% |
| 30 Sep, 19 | 5,572,815 | -1.43% |
| 30 Jun, 19 | 5,653,725 | - |
IDEAYA Biosciences (IDYA) has 14.20M shares outstanding as of 30 Jun 24, down -82.03% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 18.22% | 0.16% |
| 31 Mar, 24 | 105.22% | 1.02% |
| 31 Dec, 23 | 101.36% | 1.02% |
| 30 Sep, 23 | 99.49% | 0.98% |
| 30 Jun, 23 | 100.60% | 1.14% |
| 31 Mar, 23 | 94.14% | 1.03% |
| 31 Dec, 22 | 95.71% | 0.78% |
| 30 Sep, 22 | 110.96% | 1.32% |
| 30 Jun, 22 | 91.65% | 1.11% |
| 31 Mar, 22 | 90.88% | 0.94% |
| 31 Dec, 21 | 98.51% | 1.27% |
| 30 Sep, 21 | 87.93% | 1.47% |
| 30 Jun, 21 | 77.32% | 1.37% |
| 31 Mar, 21 | 74.99% | 1.11% |
| 31 Dec, 20 | 82.05% | 1.86% |
| 30 Sep, 20 | 66.48% | 0.86% |
| 30 Jun, 20 | 87.90% | 3.02% |
| 31 Mar, 20 | 53.93% | 1.77% |
| 31 Dec, 19 | 55.12% | 7.21% |
| 30 Sep, 19 | 27.65% | 3.40% |
| 30 Jun, 19 | 28.53% | - |
As of 30 Jun 24, IDEAYA Biosciences is held by 18.22% institutional shareholders, representing a 0.16% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 41 | -69.63% |
| 31 Mar, 24 | 135 | 33.66% |
| 31 Dec, 23 | 101 | 24.69% |
| 30 Sep, 23 | 81 | -20.59% |
| 30 Jun, 23 | 102 | 37.84% |
| 31 Mar, 23 | 74 | - |
| 31 Dec, 22 | 74 | - |
| 30 Sep, 22 | 74 | 94.74% |
| 30 Jun, 22 | 38 | -32.14% |
| 31 Mar, 22 | 56 | -24.32% |
| 31 Dec, 21 | 74 | 23.33% |
| 30 Sep, 21 | 60 | 20.00% |
| 30 Jun, 21 | 50 | 2.04% |
| 31 Mar, 21 | 49 | -7.55% |
| 31 Dec, 20 | 53 | 29.27% |
| 30 Sep, 20 | 41 | -26.79% |
| 30 Jun, 20 | 56 | 460.00% |
| 31 Mar, 20 | 10 | -33.33% |
| 31 Dec, 19 | 15 | 66.67% |
| 30 Sep, 19 | 9 | -62.50% |
| 30 Jun, 19 | 24 | - |
41 institutional shareholders have increased their position in IDYA stock as of 30 Jun 24 compared to 135 in the previous quarter (a -69.63% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -73.08% |
| 31 Mar, 24 | 52 | 26.83% |
| 31 Dec, 23 | 41 | 5.13% |
| 30 Sep, 23 | 39 | 44.44% |
| 30 Jun, 23 | 27 | -10.00% |
| 31 Mar, 23 | 30 | 11.11% |
| 31 Dec, 22 | 27 | 22.73% |
| 30 Sep, 22 | 22 | -42.11% |
| 30 Jun, 22 | 38 | 26.67% |
| 31 Mar, 22 | 30 | 25.00% |
| 31 Dec, 21 | 24 | 50.00% |
| 30 Sep, 21 | 16 | - |
| 30 Jun, 21 | 16 | -33.33% |
| 31 Mar, 21 | 24 | 84.62% |
| 31 Dec, 20 | 13 | - |
| 30 Sep, 20 | 13 | 333.33% |
| 30 Jun, 20 | 3 | -40.00% |
| 31 Mar, 20 | 5 | -28.57% |
| 31 Dec, 19 | 7 | - |
| 30 Sep, 19 | 7 | - |
| 30 Jun, 19 | - | - |
14 institutional shareholders have reduced their position in IDYA stock as of 30 Jun 24 compared to 52 in the previous quarter (a -73.08% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 67 | -67.48% | 14,201,004 | -82.03% | 18.22% | 0.16% | 41 | -69.63% | 14 | -73.08% |
| 31 Mar, 24 | 206 | 29.56% | 79,028,458 | 19.50% | 105.22% | 1.02% | 135 | 33.66% | 52 | 26.83% |
| 31 Dec, 23 | 159 | 8.90% | 66,131,446 | 10.78% | 101.36% | 1.02% | 101 | 24.69% | 41 | 5.13% |
| 30 Sep, 23 | 146 | 2.82% | 59,696,179 | 5.49% | 99.49% | 0.98% | 81 | -20.59% | 39 | 44.44% |
| 30 Jun, 23 | 142 | 11.81% | 56,588,010 | 24.27% | 100.60% | 1.14% | 102 | 37.84% | 27 | -10.00% |
| 31 Mar, 23 | 127 | 4.96% | 45,537,780 | -1.15% | 94.14% | 1.03% | 74 | - | 30 | 11.11% |
| 31 Dec, 22 | 121 | 6.14% | 46,069,105 | 3.02% | 95.71% | 0.78% | 74 | - | 27 | 22.73% |
| 30 Sep, 22 | 114 | 16.33% | 44,716,764 | 26.20% | 110.96% | 1.32% | 74 | 94.74% | 22 | -42.11% |
| 30 Jun, 22 | 98 | -5.77% | 35,432,949 | 1.03% | 91.65% | 1.11% | 38 | -32.14% | 38 | 26.67% |
| 31 Mar, 22 | 104 | -6.31% | 35,072,346 | 0.99% | 90.88% | 0.94% | 56 | -24.32% | 30 | 25.00% |
| 31 Dec, 21 | 111 | 23.33% | 34,727,068 | 5.71% | 98.51% | 1.27% | 74 | 23.33% | 24 | 50.00% |
| 30 Sep, 21 | 90 | 8.43% | 32,852,571 | 29.33% | 87.93% | 1.47% | 60 | 20.00% | 16 | - |
| 30 Jun, 21 | 83 | -8.79% | 25,402,126 | 6.65% | 77.32% | 1.37% | 50 | 2.04% | 16 | -33.33% |
| 31 Mar, 21 | 91 | 9.64% | 23,818,104 | 17.42% | 74.99% | 1.11% | 49 | -7.55% | 24 | 84.62% |
| 31 Dec, 20 | 83 | 25.76% | 20,283,888 | 7.44% | 82.05% | 1.86% | 53 | 29.27% | 13 | - |
| 30 Sep, 20 | 66 | 4.76% | 18,878,404 | 2.26% | 66.48% | 0.86% | 41 | -26.79% | 13 | 333.33% |
| 30 Jun, 20 | 63 | 142.31% | 18,460,926 | 69.04% | 87.90% | 3.02% | 56 | 460.00% | 3 | -40.00% |
| 31 Mar, 20 | 26 | -13.33% | 10,921,124 | -2.08% | 53.93% | 1.77% | 10 | -33.33% | 5 | -28.57% |
| 31 Dec, 19 | 30 | 25.00% | 11,153,168 | 100.14% | 55.12% | 7.21% | 15 | 66.67% | 7 | - |
| 30 Sep, 19 | 24 | - | 5,572,815 | -1.43% | 27.65% | 3.40% | 9 | -62.50% | 7 | - |
| 30 Jun, 19 | 24 | - | 5,653,725 | - | 28.53% | - | 24 | - | - | - |
IDEAYA Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of IDEAYA Biosciences's stock was made by Throne Jason on Jun 27 2024, selling 6,424 shares at $13.34 per share (valued at $85.70K).
IDEAYA Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 13 | 15 | 86.67% |
| Q1 2024 | 10 | 14 | 71.43% |
| Q4 2023 | 4 | 9 | 44.44% |
| Q3 2023 | 6 | 24 | 25.00% |
| Q2 2023 | 13 | 8 | 162.50% |
| Q1 2023 | 5 | - | - |
| Q4 2022 | - | 1 | - |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 3 | 1 | 300.00% |
| Q4 2021 | 2 | 3 | 66.67% |
| Q3 2021 | 10 | 25 | 40.00% |
| Q2 2021 | 11 | 8 | 137.50% |
| Q1 2021 | 13 | 15 | 86.67% |
| Q4 2020 | 3 | 7 | 42.86% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 20 | 16 | 125.00% |
| Q1 2020 | 6 | 1 | 600.00% |
| Q4 2019 | 2 | - | - |
| Q3 2019 | 9 | 4 | 225.00% |
| Q2 2019 | 28 | 40 | 70.00% |
13 total buy trades, and 15 total sell trades (buy/sell ratio of 0.87%) were made by IDEAYA Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 9 | - |
| Q1 2024 | - | 9 | - |
| Q4 2023 | - | 5 | - |
| Q3 2023 | - | 13 | - |
| Q2 2023 | - | 3 | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 2 | - |
| Q3 2021 | - | 15 | - |
| Q2 2021 | - | 4 | - |
| Q1 2021 | - | 9 | - |
| Q4 2020 | - | 5 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 9 | 8 | 112.50% |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 10 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 9 open market sell trades of IDEAYA Biosciences's stocks.
IDEAYA Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| RVMD | Revolution Medicines, Inc. Warrant |
| DAWN | Day One Biopharmaceuticals, Inc. |
| MGTX | MeiraGTx Holdings plc |
| VTYX | Ventyx Biosciences, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| RNA | Avidity Biosciences, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KROS | Keros Therapeutics, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| ABOS | Acumen Pharmaceuticals, Inc. |
| SWTX | SpringWorks Therapeutics, Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| FIXX | Q32 Bio Inc. |
| VRNA | Verona Pharma plc |
| AMLX | Amylyx Pharmaceuticals, Inc. |
IDYA Ownership FAQ
Who Owns IDEAYA Biosciences?
IDEAYA Biosciences is owned by institutional shareholders (18.22%), insiders (1.06%), and public (80.72%). The largest institutional shareholder of IDEAYA Biosciences is FMR LLC (14.46% of total shares) and the top mutual fund owner is T. Rowe Price New Horizons Fund, Inc. (0.35% of total shares).
Who are the major institutional shareholders of IDEAYA Biosciences?
IDEAYA Biosciences's major institutional shareholders are FMR LLC, BLACKROCK INC., FEDERATED HERMES, INC., VANGUARD GROUP INC, and JANUS HENDERSON GROUP PLC. The top five shareholders own together 40.12% of the company's share outstanding.
How many IDEAYA Biosciences shareholders are there?
As of Jun 2024, there are 67 institutional shareholders of IDEAYA Biosciences.
What percentage of IDEAYA Biosciences is owned by FMR LLC?
FMR LLC owns 11.27M shares of IDEAYA Biosciences, representing 14.46% of the company's total shares outstanding, valued at $395.69M (as of Jun 2024).
What percentage of IDEAYA Biosciences is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 6.81M shares of IDEAYA Biosciences (IDYA), compromising 8.73% of the company, valued at $239.02M.
What percentage of IDEAYA Biosciences is owned by FEDERATED HERMES, INC?
FEDERATED HERMES, INC is the third largest holder of IDEAYA Biosciences. The company owns 4.86M of the company's shares outstanding (worth $170.49B).